about
Molecular pathology of ataxia telangiectasiaThe molecular pathology of primary immunodeficienciesTargeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerEvery amino acid matters: essential contributions of histone variants to mammalian development and diseaseSapacitabine for cancerLow ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.Loss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesisHistone variants: emerging players in cancer biology.Synthetic cytotoxicity: digenic interactions with TEL1/ATM mutations reveal sensitivity to low doses of camptothecinATM and ataxia telangiectasia.Multifunctional role of ATM/Tel1 kinase in genome stability: from the DNA damage response to telomere maintenanceMutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency.Development of a murine model for blastoid variant mantle-cell lymphomaConcurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.DNA Repair Cofactors ATMIN and NBS1 Are Required to Suppress T Cell Activation.ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection.H2AX haploinsufficiency modifies genomic stability and tumor susceptibilityEffective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell linesThe orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib.Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients.Prenatal exposure to flavonoids: implication for cancer risk.Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
P2860
Q24672363-FFC66984-48E5-4AEC-BD56-B6A49596EB53Q24685932-7A76D693-729E-4291-BA32-38875A6AD96EQ26743378-2774A517-9D53-4B93-AC46-7A4DF1B2F91BQ27008522-9405F4D9-4FD4-49F8-9E87-B09F8FB4BEF6Q27024675-E97F0AD8-A958-4F48-B068-DDBBC65840D1Q27853007-FA33F235-A70F-40F9-AD1D-6B41E1F36597Q28477245-DD0D664B-EAAA-4C30-A4AC-5AC6280AEF1AQ33630867-90428C6D-05B8-4D33-ADB8-650CF220A0BEQ33779587-7BAF04A1-26B5-48EE-B59F-FC9AF0A3842DQ34166198-F29737DF-346F-480E-9787-6968B919DDF0Q34176919-6FB1408C-2FC0-404F-91A9-2F25593BB249Q34479078-3DCD76C5-4B8F-47F9-9CBA-2501E6236AB9Q35533606-391A2C03-8F61-4CDF-8AB4-F293A146C7CFQ35828767-D78B5479-7ECC-4296-8241-3AA944B27718Q35832062-30F52736-42D0-4B5E-8D99-049DD2EBF2A8Q36257283-C89F2393-1522-417B-A834-6B601C81EBB9Q36274840-DBF61FA5-177A-43BB-A81C-1E4D284D28D0Q36382754-0161E1E5-B5D3-41E0-A690-FDF4D9CDAD52Q36533572-50D0F286-66E6-480D-ACAF-43FE7F2A9243Q36556389-55E07E9D-C841-4887-8DA8-A7901282083FQ36688959-25FC6F1B-CC2B-4A93-B6AF-B8E4C3705E41Q37049035-72CACACF-C3BE-477A-8D72-57890E875184Q37633188-FCE9F2E0-7180-4D9F-9EC3-C778074EFA59Q42399864-BBD7DAD3-896B-4920-B587-D1477C1136A9Q42774030-98C8CAA4-5ABA-4B52-98F2-9E7151EB4029Q47615958-E6A596A4-C4BB-4870-B35C-081E3422E02E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
ATM mutations in sporadic lymphoid tumours.
@ast
ATM mutations in sporadic lymphoid tumours.
@en
ATM mutations in sporadic lymphoid tumours.
@nl
type
label
ATM mutations in sporadic lymphoid tumours.
@ast
ATM mutations in sporadic lymphoid tumours.
@en
ATM mutations in sporadic lymphoid tumours.
@nl
prefLabel
ATM mutations in sporadic lymphoid tumours.
@ast
ATM mutations in sporadic lymphoid tumours.
@en
ATM mutations in sporadic lymphoid tumours.
@nl
P2093
P2860
P1433
P1476
ATM mutations in sporadic lymphoid tumours
@en
P2093
P2860
P304
P356
10.1080/1042819021000002884
P577
2002-08-01T00:00:00Z